BRPI1013539A2 - composição farmacêutica sublingual compreendendo um óleo neutro - Google Patents

composição farmacêutica sublingual compreendendo um óleo neutro

Info

Publication number
BRPI1013539A2
BRPI1013539A2 BRPI1013539A BRPI1013539A BRPI1013539A2 BR PI1013539 A2 BRPI1013539 A2 BR PI1013539A2 BR PI1013539 A BRPI1013539 A BR PI1013539A BR PI1013539 A BRPI1013539 A BR PI1013539A BR PI1013539 A2 BRPI1013539 A2 BR PI1013539A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
neutral oil
sublingual pharmaceutical
sublingual
neutral
Prior art date
Application number
BRPI1013539A
Other languages
English (en)
Portuguese (pt)
Inventor
Clive Booles
Original Assignee
Londonpharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/GB2009/050416 external-priority patent/WO2010122276A1/en
Priority claimed from GB0906977A external-priority patent/GB2469792A/en
Application filed by Londonpharma Ltd filed Critical Londonpharma Ltd
Publication of BRPI1013539A2 publication Critical patent/BRPI1013539A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI1013539A 2009-04-23 2010-04-23 composição farmacêutica sublingual compreendendo um óleo neutro BRPI1013539A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/GB2009/050416 WO2010122276A1 (en) 2009-04-23 2009-04-23 Drug delivery
GB0906977A GB2469792A (en) 2009-04-23 2009-04-23 Oil-based pharmaceutical formulation for sublingual delivery
PCT/GB2010/050671 WO2010122355A1 (en) 2009-04-23 2010-04-23 Sublingual pharmaceutical composition comprising a neutral oil

Publications (1)

Publication Number Publication Date
BRPI1013539A2 true BRPI1013539A2 (pt) 2016-04-12

Family

ID=42236683

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1013539A BRPI1013539A2 (pt) 2009-04-23 2010-04-23 composição farmacêutica sublingual compreendendo um óleo neutro

Country Status (15)

Country Link
US (1) US20120058158A1 (OSRAM)
EP (1) EP2421503A1 (OSRAM)
JP (1) JP2012524771A (OSRAM)
CN (1) CN102458358A (OSRAM)
AU (1) AU2010240653A1 (OSRAM)
BR (1) BRPI1013539A2 (OSRAM)
CA (1) CA2756879A1 (OSRAM)
IL (1) IL215454A (OSRAM)
MX (1) MX2011010835A (OSRAM)
MY (1) MY167918A (OSRAM)
NZ (1) NZ595467A (OSRAM)
RU (1) RU2011139638A (OSRAM)
SG (1) SG175160A1 (OSRAM)
WO (1) WO2010122355A1 (OSRAM)
ZA (1) ZA201107089B (OSRAM)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
US10512644B2 (en) 2007-03-12 2019-12-24 Inheris Pharmaceuticals, Inc. Oligomer-opioid agonist conjugates
US8173666B2 (en) 2007-03-12 2012-05-08 Nektar Therapeutics Oligomer-opioid agonist conjugates
MX354603B (es) 2007-05-25 2018-03-13 Indivior Uk Ltd Formulaciones de transferencia sostenida de compuestos de risperidona.
GB0720967D0 (en) * 2007-10-25 2007-12-05 Protophama Ltd Anti-material pharmaceutical composition
US9272044B2 (en) 2010-06-08 2016-03-01 Indivior Uk Limited Injectable flowable composition buprenorphine
GB2481017B (en) 2010-06-08 2015-01-07 Rb Pharmaceuticals Ltd Microparticle buprenorphine suspension
US20130254139A1 (en) * 2012-03-21 2013-09-26 Xiaoguang Lei Systems and methods for building a universal intelligent assistant with learning capabilities
GB201404139D0 (en) 2014-03-10 2014-04-23 Rb Pharmaceuticals Ltd Sustained release buprenorphine solution formulations
US10376586B2 (en) * 2016-02-16 2019-08-13 Entourage Bioscience, LLC Method and compositions for solubilizing non-polar constituents
KR20190005199A (ko) * 2016-05-05 2019-01-15 어퀘스티브 테라퓨틱스, 아이엔씨. 강화된 전달 에프네프린 조성물
US12433850B2 (en) 2016-05-05 2025-10-07 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine and prodrug compositions
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
US12427121B2 (en) 2016-05-05 2025-09-30 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine compositions
CN110325179A (zh) * 2016-12-26 2019-10-11 塞尔利克斯生物私人有限公司 用于治疗慢性疼痛的组合物和方法
IL313551A (en) * 2017-09-27 2024-08-01 Aquestive Therapeutics Inc Enhanced delivery epinephrine and prodrug compositions
US12390488B2 (en) 2018-12-29 2025-08-19 Solventum Intellectual Properties Company Oral articles and methods of use
CA3178140A1 (en) * 2020-03-31 2021-10-07 Nomoreitis B.V. Treatment of hyperinflammatory syndrome
US12465564B2 (en) 2021-10-25 2025-11-11 Aquestive Therapeutics, Inc. Oral and nasal compositions and methods of treatment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3775960D1 (de) * 1986-03-10 1992-02-27 Burghart Kurt Pharmazeutische zubereitung sowie verfahren zur herstellung derselben.
US5955098A (en) * 1996-04-12 1999-09-21 Flemington Pharmaceutical Corp. Buccal non polar spray or capsule
US20050281752A1 (en) * 1997-10-01 2005-12-22 Dugger Harry A Iii Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
EP2298284A3 (en) * 2001-02-14 2013-12-18 GW Pharma Limited Mucoadhesive pharmaceutical formulations
RU2432950C2 (ru) * 2006-01-25 2011-11-10 Инсис Терапьютикс Инк. Подъязычный спрей на основе фентанила
JP2010535774A (ja) * 2007-08-06 2010-11-25 インシス セラピューティクス インコーポレイテッド 経口カンナビノイド液体製剤および治療方法
GB0720967D0 (en) * 2007-10-25 2007-12-05 Protophama Ltd Anti-material pharmaceutical composition
BRPI1014887A8 (pt) * 2009-04-23 2019-02-12 Londonpharma Ltd composição farmacêutica para uso no tratamento de neoplasias e uso de um composto provendo di-hidroartemesinina via dosagem sublingual, transmucosal, bucal ou nasal

Also Published As

Publication number Publication date
CN102458358A (zh) 2012-05-16
JP2012524771A (ja) 2012-10-18
US20120058158A1 (en) 2012-03-08
CA2756879A1 (en) 2010-10-28
WO2010122355A1 (en) 2010-10-28
ZA201107089B (en) 2012-12-27
IL215454A (en) 2014-11-30
EP2421503A1 (en) 2012-02-29
AU2010240653A1 (en) 2011-10-20
SG175160A1 (en) 2011-11-28
MX2011010835A (es) 2012-05-08
RU2011139638A (ru) 2013-05-27
NZ595467A (en) 2013-08-30
IL215454A0 (en) 2011-12-29
MY167918A (en) 2018-09-27

Similar Documents

Publication Publication Date Title
BRPI1013539A2 (pt) composição farmacêutica sublingual compreendendo um óleo neutro
FR2944289B1 (fr) Composition huileuse volatile
DK3078664T3 (da) Antiparasitiske dihydroazol-sammensætninger
EP2488022A4 (en) Compositions
SMT201600307B (it) Composizione liposomiale
UY33161A (es) Composiciones plaguicidas
DOP2011000396A (es) Composiciones novedosas
BRPI1013588A2 (pt) composição
DK3097925T3 (da) Farmaceutisk sammensætning
BR112012005242A2 (pt) composição de óleo anticorrosivo
BRPI1012539A2 (pt) composições farmacêuticas
BRPI1006505A2 (pt) embalagem
BR112012003977A2 (pt) composições que induzem ajuda de célula t
BRPI1004940A2 (pt) composição farmacêutica
BRPI1015474A2 (pt) composição
BRPI1010690A2 (pt) composições
BRPI1015939A2 (pt) composição farmacêutica
IT1394400B1 (it) Composizioni farmaceutiche
DK2339208T3 (da) Gear
BRPI0923528A2 (pt) engrenagem intermediária
BRPI1005318A2 (pt) composição
EP2394634A4 (en) COMPOSITION CONTAINING HESPERIDINE
BR112012001340A2 (pt) composições farmacêuticas
BR112012003149A2 (pt) composição farmacêutica
EP2413905A4 (en) FORMULATION

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL